COVID — Total Revenue
Moderna COVID — Total Revenue decreased by 46.3% to $345.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 310.7%, from $84.00M to $345.00M. Over 2 years (FY 2022 to FY 2025), COVID — Total Revenue shows a downward trend with a -68.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates higher market penetration or demand for the vaccine, while a decrease suggests declining market share, reduced booster uptake, or increased competition in the respiratory vaccine space.
Detailed definition
This metric represents the total gross revenue generated from the sale of COVID-19 vaccine products within a specific re...
Peer comparison
Comparable to seasonal influenza vaccine revenue or other pandemic-related therapeutic product lines at major pharmaceutical and biotechnology firms.
mrna_segment_covid_total_revenueHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.61B | $4.61B | $4.61B | $4.61B | $1.76B | $2.79B | $167.00M | $184.00M | $1.81B | $923.00M | $84.00M | $114.00M | $971.00M | $642.00M | $345.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -61.9% | +59.0% | -94.0% | +10.2% | +883.7% | -49.0% | -90.9% | +35.7% | +751.8% | -33.9% | -46.3% |
| YoY Change | — | — | — | — | -61.9% | -39.4% | — | — | +3.0% | -67.0% | -49.7% | -38.0% | -46.4% | -30.4% | +310.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Moderna's covid — total revenue?
- Moderna (MRNA) reported covid — total revenue of $345.00M in Q1 2026.
- How has Moderna's covid — total revenue changed year-over-year?
- Moderna's covid — total revenue increased by 310.7% year-over-year, from $84.00M to $345.00M.
- What is the long-term trend for Moderna's covid — total revenue?
- Over 2 years (2022 to 2025), Moderna's covid — total revenue has grown at a -68.7% compound annual growth rate (CAGR), from $18.44B to $1.81B.
- What does covid — total revenue mean?
- The total sales revenue generated specifically from COVID-19 vaccine products.